Related Experiment Video
Updated: May 17, 2025
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
Molecular Profiling of Nasopharyngeal Carcinoma Using the AACR Project GENIE Repository
Beau Hsia1, Asritha Sure2, Roshan Dongre3
1School of Medicine, Creighton University, Phoenix, AZ 85012, USA.
Background:
Nasopharyngeal carcinoma (NPC) is a rare head and neck cancer arising from the mucosal lining of the nasopharynx, for which systemic therapeutic options remain scarce, reflecting the limited characterization of its genomic profile. This study utilized a large patient-level genomic repository to characterize genetic alterations, identify potential therapeutic targets, and improve disease modeling in NPC.
Methods:
A retrospective analysis of NPC samples was conducted using the AACR Project GENIE database. Targeted sequencing data were analyzed for recurrent somatic mutations, tumor mutational burden, and chromosomal copy number variations, with significance set at p < 0.05.
Results:
Frequent mutations were identified in KMT2D (20%), TP53 (16%), CYLD (9.6%), NFKBIA (6.4%), and PIK3CA (5.6%), implicating the p53, NF-κB, and PI3K pathways in NPC development. Notably, significantly distinct mutational profiles were observed based on both sex and race, with female patients exhibiting higher frequencies of PIK3C2G, ETV6, and CDKN1B mutations and non-Asian patients showing enrichment in KDM5A, CCND2, and TP53 mutations.
Conclusions:
This study presents a detailed genomic profile of NPC, identifying key mutations within established cancer-associated pathways. The identification of frequently mutated pathways (p53, NF-κB, and PI3K) suggests potential targets for novel therapies. Furthermore, distinct mutational landscapes in female and Asian NPC patients offer possibilities for precision therapeutic interventions.
Insights
Nasopharyngeal carcinoma (NPC) genomic profiling reveals frequent mutations in key cancer pathways. Distinct genetic profiles in female and non-Asian patients suggest avenues for targeted therapies.
Area of Science:
- Oncology
- Genomics
- Cancer Research
Background:
- Nasopharyngeal carcinoma (NPC) is a rare head and neck cancer with limited systemic treatment options.
- Genomic characterization of NPC is crucial for understanding its development and identifying therapeutic targets.
Purpose of the Study:
- To characterize the genomic profile of NPC using a large patient-level genomic repository.
- To identify potential therapeutic targets and improve NPC disease modeling.
- To investigate distinct mutational profiles based on patient demographics.
Main Methods:
- Retrospective analysis of NPC samples from the AACR Project GENIE database.
- Targeted sequencing data analysis for recurrent somatic mutations, tumor mutational burden, and copy number variations.
- Statistical significance set at p < 0.05.
Main Results:
- Frequent mutations identified in KMT2D (20%), TP53 (16%), CYLD (9.6%), NFKBIA (6.4%), and PIK3CA (5.6%).
- Mutations implicate the p53, NF-κB, and PI3K pathways in NPC development.
- Distinct mutational profiles observed in female patients (PIK3C2G, ETV6, CDKN1B) and non-Asian patients (KDM5A, CCND2, TP53).
Conclusions:
- Detailed genomic profile of NPC identified key mutations in cancer-associated pathways.
- p53, NF-κB, and PI3K pathways represent potential targets for novel NPC therapies.
- Sex- and race-specific mutational landscapes offer opportunities for precision therapeutic interventions in NPC.
More Related Videos
13:19Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
11:02Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
Published on: October 18, 2013